Early withdrawal of statin therapy in patients with non-ST-segment elevation myocardial infarction - National Registry of Myocardial Infarction

被引:108
作者
Spencer, FA
Fonarow, GC
Frederick, PD
Wright, RS
Every, N
Goldberg, RJ
Gore, JM
Dong, W
Becker, RC
French, W
机构
[1] Univ Massachusetts, Sch Med, Dept Med, Div Cardiovasc Med, Worcester, MA 01655 USA
[2] Univ Calif Los Angeles, Cardiomyopathy Ctr, Div Cardiol, Los Angeles, CA USA
[3] Ovat Res Grp, Seattle, WA USA
[4] Mayo Clin, Dept Med, Rochester, MN USA
[5] Univ Washington, Dept Med, Seattle, WA 98195 USA
[6] Genentech Inc, San Francisco, CA 94080 USA
[7] Duke Univ, Dept Med, Durham, NC USA
[8] Harbor UCLA Med Ctr, Dept Med, Los Angeles, CA USA
关键词
D O I
10.1001/archinte.164.19.2162
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: There is increasing interest in the nonlipid-lowering effects of statins and their effect on outcomes in patients with acute coronary syndrome. It has been suggested that withdrawal of statin therapy during an acute coronary syndrome may attenuate any benefits of pretreatment, thereby providing indirect evidence of the importance of their non-lipid-lowering effects. Methods: This observational study compared the demographic and clinical characteristics and hospital outcomes in patients, with non-ST-segment elevation myocardial infarction enrolled in the National Registry of Myocardial Infarction 4. Comparison groups consisted of patients previously receiving statins who also received statins within 24 hours of hospital admission (n=9001), patients previously using statins in whom therapy was discontinued (n=4870), and patients who did not receive statins at any time before or during hospitalization (n=54635). Results: Of 13 871 patients receiving statins before hospital admission, 35.1% had treatment withdrawn during the first 24 hours of hospitalization. These patients had increased hospital morbidity and mortality rates relative to patients in whom therapy was continued, with higher rates of heart failure, ventricular arrhythmias, shock, and death. In multivariate analyses, these patients were at statistically significant increased risk of hose pital death compared with those continuing statin therapy and at similar risk compared with those not receiving statins before or during hospitalization. Conclusions: withdrawal of statin therapy in the first 24 hours of hospitalization for non-ST-segment elevation myocardial infarction is associated with worse hospital outcomes. In the absence of data from randomized clinical trials, our findings suggest that statin therapy should be continued during hospitalization for myocardial infarction unless strongly contraindicated.
引用
收藏
页码:2162 / 2168
页数:7
相关论文
共 22 条
[1]   Effect of statin therapy on C-reactive protein levels - The Pravastatin Inflammation/CRP Evaluation (PRINCE): A randomized trial and cohort study [J].
Albert, MA ;
Danielson, E ;
Rifai, N ;
Ridker, PM .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (01) :64-70
[2]   Use of reperfusion therapy for acute myocardial infarction in the United States - Data from the National Registry of Myocardial Infarction 2 [J].
Barron, HV ;
Bowlby, LJ ;
Breen, T ;
Rogers, WJ ;
Canto, JG ;
Zhang, YA ;
Tiefenbrunn, AJ ;
Weaver, WD .
CIRCULATION, 1998, 97 (12) :1150-1156
[3]   Pro-apoptotic effect of fluvastatin on human smooth muscle cells [J].
Buemi, M ;
Allegra, A ;
Senatore, M ;
Marino, D ;
Medici, MA ;
Aloisi, C ;
Di Pasquale, G ;
Corica, F .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1999, 370 (02) :201-203
[4]   Pravastatin treatment increases collagen content and decreases lipid content, inflammation, metalloproteinases, and cell death in human carotid plaques - Implications for plaque stabilization [J].
Crisby, M ;
Nordin-Fredriksson, G ;
Shah, PK ;
Yano, J ;
Zhu, J ;
Nilsson, J .
CIRCULATION, 2001, 103 (07) :926-933
[5]   Cholesterol reduction rapidly improves endothelial function after acute coronary syndromes -: The RECIFE (reduction of cholesterol in ischemia and function of the endothelium) trial [J].
Dupuis, J ;
Tardif, JC ;
Cernacek, P ;
Théroux, P .
CIRCULATION, 1999, 99 (25) :3227-3233
[6]   Improved treatment of coronary heart disease by implementation at a Cardiac Hospitalization Atherosclerosis Management Program (CHAMP) [J].
Fonarow, GC ;
Gawlinski, A ;
Moughrabi, S ;
Tillisch, IH .
AMERICAN JOURNAL OF CARDIOLOGY, 2001, 87 (07) :819-822
[7]  
Fukumoto Y, 2001, CIRCULATION, V103, P993
[8]   Withdrawal of statins increases event rates in patients with acute coronary syndromes [J].
Heeschen, C ;
Hamm, CW ;
Laufs, U ;
Snapinn, S ;
Böhm, M ;
White, HD .
CIRCULATION, 2002, 105 (12) :1446-1452
[9]   Effects of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors, atorvastatin and simvastatin, on the expression of endothelin-1 and endothelial nitric oxide synthase in vascular endothelial cells [J].
Hernández-Perera, O ;
Pérez-Sala, D ;
Navarro-Antolín, J ;
Sánchez-Pascuala, R ;
Hernández, G ;
Díaz, C ;
Lamas, S .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (12) :2711-2719
[10]  
Laufs U, 2000, CIRCULATION, V102, P3104